Related Experiment Video

Updated: Jul 5, 2026

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

The 5-HT7 receptor: a target for novel therapeutic avenues?

J A Terrón1

  • 1Sección de Terapéutica Experimental, Departamento de Farmacología y Toxicología, CINVESTAV IPN, Ap Postal 22026, 14000 Mexico City, Mexico. terronja@mpsnet.com.mx

Idrugs : the Investigational Drugs Journal
|May 10, 2008
PubMed

Insights

The 5-HT7 receptor plays a role in mood, sleep, and sensory processing. Further research is needed to confirm its involvement in human diseases like migraine and its therapeutic potential.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • The 5-HT7 receptor is gaining attention for its roles in physiological and pathophysiological processes.
  • Evidence links the 5-HT7 receptor to the regulation of limbic processes, circadian rhythms, and sensory processing.

Purpose of the Study:

  • To review the current understanding of the 5-HT7 receptor's characteristics.
  • To explore its potential physiological and pathophysiological relevance.
  • To provide an overview of 5-HT7 receptor ligands, including therapeutic agents.

Main Methods:

  • Literature review of existing research on the 5-HT7 receptor.
  • Analysis of studies investigating the receptor's physiological and pathological roles.
  • Compilation of information on high-affinity 5-HT7 receptor ligands.

Main Results:

  • The 5-HT7 receptor is implicated in mood regulation, circadian rhythms, and sensory processing.
  • Emerging evidence suggests a role in migraine pathogenesis and sympathetic pathway modulation.
  • Its direct involvement in human pathology and therapeutics requires further investigation.

Conclusions:

  • The 5-HT7 receptor is a significant target for understanding neurological and psychiatric conditions.
  • Further research is crucial to elucidate its precise role in human diseases and therapeutic applications.
  • Existing ligands offer potential starting points for developing novel treatments.

More Related Videos

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...